{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:03:54Z","timestamp":1788984234205,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministero dell\u2019Universit\u00e0 e della Ricerca, Italy","award":["PRIN-PRNN 2022 \u201cAMICI-SjS Analysis of Microbes, Immune and Clinical Insights in Sj\u00f6gren\u2019s Syndrome\u201d P2022LTTXE, CUP J53D23014150001"],"award-info":[{"award-number":["PRIN-PRNN 2022 \u201cAMICI-SjS Analysis of Microbes, Immune and Clinical Insights in Sj\u00f6gren\u2019s Syndrome\u201d P2022LTTXE, CUP J53D23014150001"]}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN-PRNN 2022 \u201cAMICI-SjS Analysis of Microbes, Immune and Clinical Insights in Sj\u00f6gren\u2019s Syndrome\u201d P2022LTTXE, CUP J53D23014150001"],"award-info":[{"award-number":["PRIN-PRNN 2022 \u201cAMICI-SjS Analysis of Microbes, Immune and Clinical Insights in Sj\u00f6gren\u2019s Syndrome\u201d P2022LTTXE, CUP J53D23014150001"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54557-2","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T22:46:07Z","timestamp":1779749167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Distinct molecular profile in Sj\u00f6gren\u2019s syndrome is associated with disease activity and clinical manifestations"],"prefix":"10.1038","volume":"16","author":[{"given":"Carlo","family":"Perricone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Cafaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Nicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Cruciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biancamaria","family":"Pianese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Dal Pozzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Cecchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Topini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onelia","family":"Bistoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Mecocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"12","key":"54557_CR1","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.55563\/clinexprheumatol\/5xq3fb","volume":"42","author":"F Tromby","year":"2024","unstructured":"Tromby, F. et al. Clinical manifestations, imaging and treatment of Sj\u00f6gren\u2019s disease: one year in review 2024. Clin. Exp. Rheumatol. 42 (12), 2322\u20132335. https:\/\/doi.org\/10.55563\/clinexprheumatol\/5xq3fb (2024).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"54557_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini, S. et al. Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin. Exp. Med. 22 (1), 9\u201325. https:\/\/doi.org\/10.1007\/s10238-021-00728-6 (2022).","journal-title":"Clin. Exp. Med."},{"key":"54557_CR3","unstructured":"Brito-Zer\u00f3n, P. et al. How immunological profile drives clinical phenotype of primary Sj\u00f6gren\u2019s syndrome at diagnosis: analysis of 10,500 patients (Sj\u00f6gren Big Data Project). Clin. Exp. Rheumatol.. 36 Suppl 112 (3) 102\u2013112. (2018)."},{"key":"54557_CR4","unstructured":"Cafaro, G. et al. Significance of anti-La\/SSB antibodies in primary Sj\u00f6gren\u2019s syndrome patients with combined positivity for anti-Ro\/SSA and salivary gland biopsy. Clinical and Experimental Rheumatology. Published online 2020."},{"issue":"8","key":"54557_CR5","doi-asserted-by":"publisher","first-page":"e167490","DOI":"10.1172\/jci.insight.167490","volume":"8","author":"T Xu","year":"2023","unstructured":"Xu, T. et al. Single-cell profiling reveals pathogenic role and differentiation trajectory of granzyme K+CD8\u2009+\u2009T cells in primary Sj\u00f6gren\u2019s syndrome. JCI Insight. 8 (8), e167490. https:\/\/doi.org\/10.1172\/jci.insight.167490 (2023).","journal-title":"JCI Insight"},{"issue":"4","key":"54557_CR6","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s10067-024-06901-y","volume":"43","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Identification and verification of inflammatory biomarkers for primary Sj\u00f6gren\u2019s syndrome. Clin. Rheumatol. 43 (4), 1335\u20131352. https:\/\/doi.org\/10.1007\/s10067-024-06901-y (2024).","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"54557_CR7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/ijms25020915","volume":"25","author":"C Chivasso","year":"2024","unstructured":"Chivasso, C. et al. Involvement of CCL2 in Salivary Gland Response to Hyperosmolar Stress Related to Sj\u00f6gren\u2019s Syndrome. Int. J. Mol. Sci. 25 (2), 915. https:\/\/doi.org\/10.3390\/ijms25020915 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"54557_CR8","doi-asserted-by":"publisher","unstructured":"Voulgarelis, M. & Tzioufas, A. G. Pathogenetic mechanisms in the initiation and perpetuation of Sj\u00f6gren\u2019s syndrome.Nat. Rev. Rheumatol. 6 (9) 529\u2009\u2013\u200937. (2010). https:\/\/doi.org\/10.1038\/nrrheum.2010.118.","DOI":"10.1038\/nrrheum.2010.118"},{"issue":"7","key":"54557_CR9","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/art.43096","volume":"77","author":"Y Nguyen","year":"2025","unstructured":"Nguyen, Y. et al. Distinct Pathophysiologic Pathways Support Stratification of Sj\u00f6gren\u2019s Disease Based on Symptoms, Clinical, and Routine Biological Data. Arthritis Rheumatol. 77 (7), 876\u2013883. https:\/\/doi.org\/10.1002\/art.43096 (2025).","journal-title":"Arthritis Rheumatol."},{"key":"54557_CR10","doi-asserted-by":"publisher","first-page":"1714624","DOI":"10.3389\/fimmu.2025.1714624","volume":"16","author":"JV Zhukova","year":"2025","unstructured":"Zhukova, J. V., Lopatnikova, J. A. & Sennikov, S. V. Structural and dynamic properties of IL1 receptors. Front. Immunol. 16, 1714624. https:\/\/doi.org\/10.3389\/fimmu.2025.1714624 (2025).","journal-title":"Front. Immunol."},{"key":"54557_CR11","doi-asserted-by":"publisher","unstructured":"Sorsa, T. et al. Matrix Metalloproteinases in Periodontal and Peri-Implant Diseases: Contribution to Their Pathogenesis, Diagnosis, and Treatment.J. Periodontal. Res. 2026. https:\/\/doi.org\/10.1111\/jre.70062.","DOI":"10.1111\/jre.70062"},{"key":"54557_CR12","doi-asserted-by":"crossref","unstructured":"Perricone, C. et al. Sjogren\u2019s syndrome: Everything you always wanted to know about genetic and epigenetic factors.Autoimmun Rev. 23 (12) 103673. doi: 10.1016\/j.autrev.2024.103673. Epub 2024 Oct 28.","DOI":"10.1016\/j.autrev.2024.103673"},{"key":"54557_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/art.39859","author":"CH Shiboski","year":"2017","unstructured":"Shiboski, C. H. et al. 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. ;69(1) 35\u201345. doi:https:\/\/doi.org\/10.1002\/art.39859 (2017)."},{"issue":"6","key":"54557_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.55563\/clinexprheumatol\/i8g5nd","volume":"39","author":"L de Wolff","year":"2021","unstructured":"de Wolff, L. et al. Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sj\u00f6gren\u2019s syndrome. Clin. Exp. Rheumatol. 39 (6), 100\u2013106. https:\/\/doi.org\/10.55563\/clinexprheumatol\/i8g5nd (2021).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"54557_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.55563\/clinexprheumatol\/mvcai5","volume":"39","author":"MG Sandoval-Flores","year":"2021","unstructured":"Sandoval-Flores, M. G., Chan-Campos, I. & Hern\u00e1ndez-Molina, G. Factors influencing the EULAR Sj\u00f6gren\u2019s Syndrome Patient-Reported Index in primary Sj\u00f6gren\u2019s syndrome. Clin. Exp. Rheumatol. 39 (6), 153\u2013158. https:\/\/doi.org\/10.55563\/clinexprheumatol\/mvcai5 (2021).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"7","key":"54557_CR16","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3390\/jcm9072299","volume":"9","author":"D Parisis","year":"2020","unstructured":"Parisis, D., Chivasso, C., Perret, J., Soyfoo, M. S. & Delporte, C. Current State of Knowledge on Primary Sj\u00f6gren\u2019s Syndrome, an Autoimmune Exocrinopathy. JCM 9 (7), 2299. https:\/\/doi.org\/10.3390\/jcm9072299 (2020).","journal-title":"JCM"},{"issue":"6","key":"54557_CR17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.pathol.2016.06.001","volume":"48","author":"M Sisto","year":"2016","unstructured":"Sisto, M., Lorusso, L. & Lisi, S. Interleukin-15 as a potential new target in Sj\u00f6gren\u2019s syndrome-associated inflammation. Pathology 48 (6), 602\u2013607. https:\/\/doi.org\/10.1016\/j.pathol.2016.06.001 (2016).","journal-title":"Pathology"},{"key":"54557_CR18","doi-asserted-by":"publisher","unstructured":"Darouni, L. et al. Interleukin 15 and autoimmune disorders: pathophysiology, therapeutic potential, and clinical implications. Inflamm Res.74 (1) 141. (2025). https:\/\/doi.org\/10.1007\/s00011-025-02084-7.","DOI":"10.1007\/s00011-025-02084-7"},{"key":"54557_CR19","doi-asserted-by":"publisher","first-page":"594620","DOI":"10.3389\/fimmu.2020.594620","volume":"11","author":"F Watkinson","year":"2021","unstructured":"Watkinson, F. et al. IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells. Front. Immunol. 11, 594620 (2021).","journal-title":"Front. Immunol."},{"issue":"4","key":"54557_CR20","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s10067-024-06901-y","volume":"43","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Identification and verification of inflammatory biomarkers for primary Sj\u00f6gren\u2019s syndrome. Clin. Rheumatol. 43 (4), 1335\u20131352. https:\/\/doi.org\/10.1007\/s10067-024-06901-y (2024).","journal-title":"Clin. Rheumatol."},{"issue":"12","key":"54557_CR21","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.3390\/biomedicines13122945","volume":"13","author":"Y Tian","year":"2025","unstructured":"Tian, Y. et al. Tissue-Resident Memory T Cells in Rheumatoid Immune Diseases: Pathogenic Mechanisms and Therapeutic Strategies. Biomedicines 13 (12), 2945. https:\/\/doi.org\/10.3390\/biomedicines13122945 (2025).","journal-title":"Biomedicines"},{"issue":"6","key":"54557_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane, S. L., Kremlev, S., Amini, S. & Sawaya, B. E. Monocyte Chemoattractant Protein-1 (MCP-1): An Overview. J. Interferon Cytokine Res. 29 (6), 313\u2013326. https:\/\/doi.org\/10.1089\/jir.2008.0027 (2009).","journal-title":"J. Interferon Cytokine Res."},{"key":"54557_CR23","doi-asserted-by":"publisher","first-page":"107598","DOI":"10.1016\/j.intimp.2021.107598","volume":"101","author":"S Singh","year":"2021","unstructured":"Singh, S., Anshita, D. & Ravichandiran, V. MCP-1: Function, regulation, and involvement in disease. Int. Immunopharmacol. 101, 107598. https:\/\/doi.org\/10.1016\/j.intimp.2021.107598 (2021).","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"54557_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.stemcr.2024.02.002","volume":"19","author":"S Yamazaki","year":"2024","unstructured":"Yamazaki, S. et al. Activated mesenchymal stem\/stromal cells promote myeloid cell differentiation via CCL2\/CCR2 signaling. Stem Cell. Rep. 19 (3), 414\u2013425 (2024).","journal-title":"Stem Cell. Rep."},{"issue":"8","key":"54557_CR25","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/rheumatology\/keq079","volume":"49","author":"N Iwamoto","year":"2010","unstructured":"Iwamoto, N. et al. Regulation of disease susceptibility and mononuclear cell infiltration into the labial salivary glands of Sj\u00f6gren\u2019s syndrome by monocyte chemotactic protein-1. Rheumatol. (Oxford). 49 (8), 1472\u20131478. https:\/\/doi.org\/10.1093\/rheumatology\/keq079 (2010).","journal-title":"Rheumatol. (Oxford)"},{"key":"54557_CR26","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3389\/fimmu.2019.02963","volume":"10","author":"J Kiripolsky","year":"2020","unstructured":"Kiripolsky, J., Romano, R. A., Kasperek, E. M., Yu, G. & Kramer, J. M. Activation of Myd88-Dependent TLRs Mediates Local and Systemic Inflammation in a Mouse Model of Primary Sj\u00f6gren\u2019s Syndrome. Front. Immunol. 10, 2963. https:\/\/doi.org\/10.3389\/fimmu.2019.02963 (2020).","journal-title":"Front. Immunol."},{"issue":"2","key":"54557_CR27","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/ijms25020915","volume":"25","author":"C Chivasso","year":"2024","unstructured":"Chivasso, C. et al. Involvement of CCL2 in Salivary Gland Response to Hyperosmolar Stress Related to Sj\u00f6gren\u2019s Syndrome. Int. J. Mol. Sci. 25 (2), 915. https:\/\/doi.org\/10.3390\/ijms25020915 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"54557_CR28","doi-asserted-by":"publisher","first-page":"106074","DOI":"10.1016\/j.ebiom.2025.106074","volume":"123","author":"S Li","year":"2026","unstructured":"Li, S. et al. Spatial transcriptomics uncovers lipid metabolic dysregulation driving immune-stroma crosstalk in Sj\u00f6gren\u2019s Disease. EBioMedicine 123, 106074. https:\/\/doi.org\/10.1016\/j.ebiom.2025.106074 (2026).","journal-title":"EBioMedicine"},{"key":"54557_CR29","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ndez-Molina, G. et al. Chemokine tear levels in primary Sj\u00f6gren\u2019s syndrome and their relationship with symptoms. Int Ophthalmol. ;42(8):2355\u20132361. (2022). https:\/\/doi.org\/10.1007\/s10792-022-02233-5.","DOI":"10.1007\/s10792-022-02233-5"},{"key":"54557_CR30","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.3389\/fimmu.2019.03047","volume":"10","author":"PCM Urbano","year":"2020","unstructured":"Urbano, P. C. M. et al. TNF\u03b1-Signaling Modulates the Kinase Activity of Human Effector Treg and Regulates IL-17A Expression. Front. Immunol. 10, 3047. https:\/\/doi.org\/10.3389\/fimmu.2019.03047 (2020).","journal-title":"Front. Immunol."},{"issue":"2","key":"54557_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.clim.2005.06.016","volume":"117","author":"P Szodoray","year":"2005","unstructured":"Szodoray, P. et al. Distinct profiles of Sj\u00f6gren\u2019s syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin. Immunol. 117 (2), 168\u2013176. https:\/\/doi.org\/10.1016\/j.clim.2005.06.016 (2005).","journal-title":"Clin. Immunol."},{"issue":"6","key":"54557_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.55563\/clinexprheumatol\/fp741f","volume":"39","author":"J Loureiro-Amigo","year":"2021","unstructured":"Loureiro-Amigo, J. et al. Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sj\u00f6gren\u2019s syndrome. Clin. Exp. Rheumatol. 39 (6), 131\u2013139. https:\/\/doi.org\/10.55563\/clinexprheumatol\/fp741f (2021).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"54557_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13075-016-1006-1","volume":"18","author":"A Nishikawa","year":"2016","unstructured":"Nishikawa, A. et al. Identification of definitive serum biomarkers associated with disease activity in primary Sj\u00f6gren\u2019s syndrome. Arthritis Res. Ther. 18 (1), 106. https:\/\/doi.org\/10.1186\/s13075-016-1006-1 (2016).","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"54557_CR34","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.3390\/ijms23031806","volume":"23","author":"I Luchian","year":"2022","unstructured":"Luchian, I., Goriuc, A., Sandu, D. & Covasa, M. The Role of Matrix Metalloproteinases (MMP-8, MMP-9, MMP-13) in Periodontal and Peri-Implant Pathological Processes. IJMS 23 (3), 1806. https:\/\/doi.org\/10.3390\/ijms23031806 (2022).","journal-title":"IJMS"},{"issue":"12","key":"54557_CR35","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1136\/ard.53.12.836","volume":"53","author":"YT Konttinen","year":"1994","unstructured":"Konttinen, Y. T. et al. Collagenase in Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 53 (12), 836\u2013839. https:\/\/doi.org\/10.1136\/ard.53.12.836 (1994).","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"54557_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3934\/molsci.2021002","volume":"8","author":"F Khuda","year":"2021","unstructured":"Khuda, F. et al. A mini review on the associations of matrix metalloproteinases (MMPs) -1, -8, -13 with periodontal disease. AIMS Mol. Sci. 8 (1), 13\u201331. https:\/\/doi.org\/10.3934\/molsci.2021002 (2021).","journal-title":"AIMS Mol. Sci."},{"issue":"8","key":"54557_CR37","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3390\/diagnostics13081401","volume":"13","author":"DN Gheorghe","year":"2023","unstructured":"Gheorghe, D. N. et al. Association between Sj\u00f6gren\u2019s Syndrome and Periodontitis: Epidemiological, Fundamental and Clinical Data: A Systematic Review. Diagnostics 13 (8), 1401. https:\/\/doi.org\/10.3390\/diagnostics13081401 (2023).","journal-title":"Diagnostics"},{"issue":"4","key":"54557_CR38","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4049\/jimmunol.1901074","volume":"204","author":"P Martin","year":"2020","unstructured":"Martin, P. et al. Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1\u03b1. J. Immunol. 204 (4), 967\u2013979. https:\/\/doi.org\/10.4049\/jimmunol.1901074 (2020).","journal-title":"J. Immunol."},{"key":"54557_CR39","doi-asserted-by":"publisher","first-page":"e61841","DOI":"10.7554\/eLife.61841","volume":"10","author":"DH Kim","year":"2021","unstructured":"Kim, D. H. et al. Induction of the IL-1RII decoy receptor by NFAT\/FOXP3 blocks IL-1\u03b2-dependent response of Th17 cells. eLife 10, e61841. https:\/\/doi.org\/10.7554\/eLife.61841 (2021).","journal-title":"eLife"},{"issue":"1","key":"54557_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12974-019-1502-8","volume":"16","author":"K B\u00e5rdsen","year":"2019","unstructured":"B\u00e5rdsen, K. et al. Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sj\u00f6gren\u2019s syndrome. J. Neuroinflammation. 16 (1), 102. https:\/\/doi.org\/10.1186\/s12974-019-1502-8 (2019).","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"54557_CR41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.pharmthera.2013.03.003","volume":"138","author":"J Li","year":"2013","unstructured":"Li, J., Wang, X., Zhang, F. & Yin, H. Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases. Pharmacol. Ther. 138 (3), 441\u2013451. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.03.003 (2013).","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"54557_CR42","doi-asserted-by":"publisher","first-page":"11897","DOI":"10.1038\/s41598-017-12282-x","volume":"7","author":"M Arce-Franco","year":"2017","unstructured":"Arce-Franco, M. et al. Functional effects of proinflammatory factors present in Sj\u00f6gren\u2019s syndrome salivary microenvironment in an in vitro model of human salivary gland. Sci. Rep. 7 (1), 11897. https:\/\/doi.org\/10.1038\/s41598-017-12282-x (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54557-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54557-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54557-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:05:37Z","timestamp":1785845137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54557-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54557"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54557-2","relation":{"references":[{"id-type":"doi","id":"10.1002\/art.39859","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23953"}}